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The holistic role of DNAmethylation in the organization of the cancer epigenome is not well understood. Here we perform
a comprehensive, high-resolution analysis of chromatin structure to compare the landscapes of HCT116 colon cancer cells
and a DNA methylation-deficient derivative. The NOMe-seq accessibility assay unexpectedly revealed symmetrical and
transcription-independent nucleosomal phasing across active, poised, and inactive genomic elements. DNA methylation
abolished this phasing primarily at enhancers and CpG island (CGI) promoters, with little effect on insulators and non-
CGI promoters. Abolishment of DNAmethylation led to the context-specific reestablishment of the poised and active states
of normal colon cells, which weremarked inmethylation-deficient cells by distinct H3K27modifications and the presence of
either well-phased nucleosomes or nucleosome-depleted regions, respectively. At higher-order genomic scales, we found
that long, H3K9me3-marked domains had lower accessibility, consistent with a more compact chromatin structure.
Taken together, our results demonstrate the nuanced and context-dependent role of DNA methylation in the functional,
multiscale organization of cancer epigenomes.
[Supplemental material is available for this article.]
Eukaryotic genomes are controlled by interrelated and mitotically
heritable sets of epigenetic mechanisms, consisting of DNAmeth-
ylation, nucleosome positioning, and histone modifications,
which cooperate to determine gene activation potential. DNA
methylation, the most clinically relevant epigenetic feature, is a
covalent addition of a methyl group on the cytosine of CpG dinu-
cleotides. In mammals, DNA methylation is required for the sup-
pression of transcriptional activity in normal cells, particularly
during imprinting, X-inactivation, and silencing of retrotranspo-
sons. Recent studies have suggested that DNA methylation may
play a role in fine-tuning or reinforcing gene silencing rather
than initiating it (Jones 2012; Rivera and Ren 2013). The majority
of the approximately 28 million CpG sites in the human genome
are normallymethylated, the exception being those located in pro-
moters, enhancers, and insulators, which can be demethylated in
cell type-specific patterns (Lister et al. 2009; Cohen et al. 2011;
Stadler et al. 2011; Ziller et al. 2013).Methylationpatterns are faith-
fully copied in a cell cycle-dependent process mediated by DNA
methyltransferases DNMT1 and DNMT3A/B, which preferentially
bind to nucleosomes (Jones and Liang 2009; Sharma et al. 2011).
The nucleosome is the primary unit of chromatin structure
and consists of 147 bp of DNAwrapped around a histone octamer
of H2A/B, H3, and H4. The organization of nucleosomes, along
with covalent modifications on the histone tails, are important
for maintaining a balance between compaction and accessibility
of the genome by transcription factors and other DNA binding
proteins during cellular processes such as transcription, replica-
tion, and repair (Li et al. 2007; Cairns 2009). The precise position-
ing of nucleosomes at gene promoters as well as noncoding
regulatory elements is an evolutionarily conserved mechanism
that plays a major role in eukaryotic transcriptional regulation
(Lorch et al. 1987; Schones et al. 2008; Kelly et al. 2010; Bell
et al. 2011). Various factors such as underlying DNA sequences, se-
quence-specific DNA binding factors, and ATP-dependent nucleo-
some remodelers are involved in the positioning of nucleosomes
(Tillo and Hughes 2009; Tillo et al. 2010; Bell et al. 2011;
Valouev et al. 2011; Zhang et al. 2011). The role of DNA methyla-
tion in directing nucleosome positioning in mammals is poorly
defined and highly controversial (Chodavarapu et al. 2010; Bell
et al. 2011; Valouev et al. 2011; Portela et al. 2013).
Epigenetic changes, in particular the aberrant DNA methyla-
tion and silencing of CpG island (CGI) promoters, are a common
signature of cancer (Baylin and Jones 2011). This early observa-
tion, alongwith the fact that >60%of promoters are locatedwithin
CGIs, has driven the focus on CGIs as a model of study for epige-
netic regulation (Tazi and Bird 1990; Irizarry et al. 2009; Deaton
and Bird 2011; Portela et al. 2013). Unbiasedwhole-genomemeth-
ylation platforms, however, have revealed that methylation
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changes at other regulatory regions such as CGI shores, non-CGI
promoters, and enhancers may also play a role in tumorigenesis
(Doi et al. 2009; Irizarry et al. 2009; Rach et al. 2011; Berman
et al. 2012; Aran and Hellman 2013; Hovestadt et al. 2014;
Taberlay et al. 2014). Epigenomic mapping projects such as the
NIH Roadmap Epigenomics Program and the ENCODE Project
Consortium (Bernstein et al. 2010; The ENCODE Project Consor-
tium 2012) have shown that distinct epigenetic marks are highly
correlated and form consistent epigenetic states (Rivera and Ren
2013). Histone marks and variants have been broadly categorized
as active (H3K27ac), permissive (H3K4me1-3, H2A.Z), or repressive
(H3K27me3, H3K9me3); and computational methods such as
chromHMMhave been used to define distinct combinatorial states
such as active versus poised promoters and enhancers (Creyghton
et al. 2010; Ernst et al. 2011; Rada-Iglesias et al. 2011). Despite ex-
tensive study on DNAmethylation changes in cancer, we still lack
an understanding of howDNAmethylation changes alter these in-
tegrated chromatin states (Jones 2012).
Here, we compare a colon cancer cell line HCT116 with its
almost completely unmethylated derivative, DKO1, to evaluate
the effects of DNA methylation on nucleosome positioning and
histone modifications. Our study couples NOMe-seq with histone
ChIP-seq and RNA-seq to generate integrated maps of chromatin
architecture and gene expression. Using the DKO1 model, which
was genetically engineered to have a complete depletion of
DNMT3B and hypomorphic expression of DNMT1 (Rhee et al.
2002), we profile the focal and long-range changes in chromatin
structures and elucidate how perturbations in global DNAmethyl-
ation pattern may directly alter the functional organization of the
cancer epigenome and thereby, gene transcription (Rhee et al.
2002; Egger et al. 2006; Sharma et al. 2011; De Carvalho et al.
2012).
Results
NOMe-seq detects nucleosome depletion at a subset of genomic
enhancers in methyltransferase-deficient DKO1 cells
Accessible or nucleosome-depleted regions (NDRs) are a distinct
feature of active regulatory elements (Kelly et al. 2012; Rivera
and Ren 2013). Using NOMe-seq, we characterized the relation-
ship between DNA methylation and chromatin accessibility by
analyzing two biological replicates each ofHCT116 and the severe-
ly hypomethylated DKO1 cells (Supplemental Table 1). We devel-
oped a hidden Markov model (HMM) approach to identify 16,245
NDRs present in one or both cell types (Fig. 1A) and confirmed the
accessibility of the HCT116NDRs by examining the publicly avail-
able ENCODE DNase hypersensitivity mapping data for HCT116
(Fig. 1B). We hierarchically clustered the NDRs into four distinct
clusters (C1–C4) and found that the vast majority (those within
clusters C1, C2, and C4) were conserved between cell types, and
the results were consistent in the second NOMe-seq replicate
(Supplemental Fig. 1A–C). Most of the NDRs in clusters C1 and
C2 were flanked on both sides by strongly phased nucleosomes
(i.e., “symmetrical” phasing) (Fig. 1A; Supplemental Fig. 1D).
The C1 and C2 NDRs were also associated with strong enrichment
of the active H3K27ac and permissive H2A.Z, H3K4me3, and
H3K4me1marks (Fig. 1B) and overlapped active and weakly active
CGI promoters in both cell types (Supplemental Fig. 1E). NDRs in
cluster C4 consisted of weak enhancers or insulators characterized
by CTCF binding sites (Supplemental Fig. 1E). The highly consis-
tent phasing patterns around the C4 CTCF sites (Supplemental
Fig. 1D) substantiated our earlier findings that DNA methylation
rates are significantly higher within internucleosome linker re-
gions than within nucleosome cores (Kelly et al. 2012; Berman
et al. 2013; Taberlay et al. 2014). DNA methylation loss in DKO1
cells did not affect the strong nucleosome positioning around
CTCF, further demonstrating that the effects of DNA methylation
on nucleosome organization are limited and context specific.
The C3 cluster contained 1485 NDRs that were specific to
DKO1 cells in both replicates (Fig. 1A; Supplemental Fig. 1A).
In HCT116, the C3 regions were characterized by high DNAmeth-
ylation and low chromatin accessibility. In addition to NDRs,
these regions acquired phasing of surrounding nucleosomes in
DKO1 (Supplemental Fig. 1D). These regions gained permissive
and active histone marks in DKO1 that were mostly absent in
HCT116 cells and were highly enriched for the “strong enhancer”
chromHMM state in DKO1 cells (Supplemental Fig. 1E). Interest-
ingly, many of these regions were premarked with low-level
H3K4me1 in HCT116, reminiscent of the H3K4me1 premarking
of “poised” enhancers and promoters in development (Creyghton
et al. 2010; Rada-Iglesias et al. 2011). Furthermore, C3 NDRs were
significantly enriched for specific transcription factor binding
motifs ARNT (also known as HIF-1beta) and FOS (AP-1 motif for
FOS/JUN dimer, Supplemental Fig. 1F), demonstrating the highly
specific nature of these enhancer changes. As a further indication
of specificity, enhancer regions defined by ENCODE chromHMM
data and NOMe-seq that were active in an unrelated cell type
(leukemia-derived K562 cells), remained inactive and did not
gain NDRs or nucleosomal phasing in DKO1 cells (Supplemental
Fig. 1G).
Loss of DNA methylation results in the reorganization
of nucleosomes and the acquisition of active and poised
chromatin marks at CGI promoters
In the clustering described above, we observed a consistent gain of
the poised CGI promoter chromHMM state across the two largest
clusters, C1 and C2 (Supplemental Fig. 1E). To systematically ad-
dress the effects of DNA methylation loss on CGI promoters, we
stratified all CGI promoters based on their methylation status in
the two cell types: UU (unmethylated in both HCT116 and
DKO1), MU (unmethylated only in DKO1), and MM (methylated
in both). We investigated chromatin features of the different CGI
promoter classes by clustering all promoters within the class based
on DKO1 accessibility (Fig. 2A). The majority of CGI promoters
(12,326) fell into the UU class, consistent with the idea that
CGIs are generally devoid of DNA methylation, even in cancer
(Weber et al. 2007; Gebhard et al. 2010; Deaton and Bird 2011).
UU promoters had an open architecture, with a highly accessible
NDR region flanked by at least three well-phased nucleosomes in
both the 5′ and 3′ directions from the TSS (Fig. 2A), and were con-
sistent in both NOMe-seq replicates (Supplemental Fig. 2). The re-
mainder of CGI promoters (3312) were methylated in HCT116
cells. A small set of these were in the MM class (96) and retained
a closed chromatin architecture inDKO1 cells; thesemay represent
a small but important set of genes with selective pressure to retain
an inactive chromatin configuration (DeCarvalho et al. 2012). The
remaining 3216 CGI promoters methylated in HCT116 fell into
the MU class. These showed a dramatic reorganization of the sur-
rounding chromatin in DKO1 cells, with newly positioned nucle-
osomes in both the 5′ and 3′ directions (Fig. 2A). The de novo
phasing around MU promoters was not an artifact of our heatmap
clustering method (Supplemental Fig. 2A); to quantify the
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increased nucleosomal phasing in DKO1 cells, we calculated the
positional autocorrelation of accessibility levels for all MU regions
(Fig. 2B).
To understand the functional relevance of the striking nucle-
osome organization changes, we analyzed histone modifica-
tions and gene expression patterns in HCT116 and DKO1 cells.
Histone modifications at UU promoters remained consistent be-
tween HCT116 and DKO1 cells, including the presence of the his-
tone variant H2A.Z, the active mark H3K27ac, and the permissive
marks H3K4me3 and H3K4me1 (Fig. 2C, Supplemental Fig. 3A).
ChromHMM states and expression levels were largely unchanged,
with most promoters having high expression and active promoter
Figure 1. NOMe-seq detects nucleosome depletion at a subset of genomic enhancers in methyltransferase-deficient DKO1 cells. (A) Our hiddenMarkov
model (HMM) identified all methyltransferase accessible regions (MARs), and those longer than 100 bp were considered nucleosome-depleted regions
(NDRs). The heatmap includes all NDRs that were overlapping between the two biological replicates of either HCT116 and DKO1 cells (n = 16,245).
NOMe-seq methylation levels (CG methylation for “DNA Methylation” and GC methylation for “Accessibility”) were aligned based on the center of
the NDR and extended by ±1 kb. NDRs were hierarchically clustered based on the accessibility within ±250 bp of NDR centers in both cell types, and dashed
horizontal lines separate the four top-level clusters. (B) ENCODE DNase hypersensitivity signal intensity is plotted for HCT116 cells for the same genomic
regions in A. (C) Enrichment level for each histone mark was calculated as Z-score against the genomic background, and the value was plotted ±5 kb from
the center of the NDRs for the same regions in A. (D) Average methylation (black) and accessibility (green) levels are shown for the altered cluster C3 (plots
for the invariant clusters C1, C2, and C4 are shown in Supplemental Fig. 1D.)
DNA methylation has context-dependent role
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status (Fig. 2D; Supplemental Fig. 3B). In contrast, CGI promoters
that were methylated in HCT116 (the MM and MU classes) were
largely devoid of all active, permissive, and repressive histone
marks in HCT116. In HCT116 cells, these promoters were unex-
pressed (Fig. 2D) and associated with inactive promoter states
(Supplemental Fig. 3B). Those that retained residual DNA methyl-
ation in DKO1 cells (the MM class) had relatively few changes in
histonemodifications (Fig. 2C), gene expression (Fig. 2D), or chro-
matin state (Supplemental Fig. 3B).
In contrast to MM promoters, those that completely lost
methylation in DKO1 (the MU class) gained the permissive
H2A.Z, H3K4me3, and H3K4me1 marks as well as the repressive
H3K27me3 mark (Fig. 2C). The acquisition of H3K27me3 with
the abolishment of DNAmethylation, but not the other repressive
mark H3K9me3, was consistent with earlier reports (Jin et al. 2009;
Komashko and Farnham 2010). This is particularly intriguing due
to the association of many of these cancer-hypermethylated CGI
promoters with H3K27me3-containing poised or bivalent states
in normal cell types (Ohm et al. 2007; Schlesinger et al. 2007;
Widschwendter et al. 2007). Furthermore, at MU promoters,
H3K4me1 was localized directly over the TSS, in contrast to its dis-
tribution at active UU promoters where two peaks flank a central
NDR (Fig. 2C; Supplemental Fig. 3A). This central H3K4me1 pat-
tern was consistent with the H3K27me3-containing poised pro-
moter state described in earlier studies (McGarvey et al. 2008;
Hawkins et al. 2010).
CGI promoters losing methylation acquire either an active or
poised chromatin state, each with a distinct nucleosomal profile,
and histone modifications that resemble their respective patterns
in normal colon cells
When investigated in detail, the 3216 MU promoters fell into two
distinct subclusters, one lacking an NDR but gaining nucleosome
Figure 2. Loss of DNA methylation results in the reorganization of nucleosomes and the acquisition of active and poised chromatin marks at CGI pro-
moters. (A) Average NOMe-seq methylation levels (CG methylation for “DNA Methylation” and GC methylation for “Accessibility”) were aligned to tran-
scription start sites (TSSs) of 15,638 CGI promoters and extended by ±1 kb. The heatmap was organized into four sections based on the DNAmethylation
levels: Unmethylated in HCT116 andUnmethylated in DKO1 (UU);Methylated in HCT116 andMethylated in DKO1 (MM); andMethylated in HCT116 and
Unmethylated in DKO1 (MU).Within each class, promoters were ordered based on hierarchical clustering of the accessibility pattern in DKO1 cells (a similar
clustering based on the accessibility of HCT116 cells is shown in Supplemental Fig. 2A). (B) In each cell type, Pearson correlations were calculated based on
methylation levels between pairs of GCs at each possible distance fromone another. Only those pairs inwhich bothGCswere from0 to 700 bp downstream
from the TSS were considered. (C ) Within each promoter class, the Z-score enrichment level of each histone mark was extended to ±3 kb around the TSS
and averaged (seeMethods for Z-score enrichment definition). (D) FPKM transcript values for all genes were divided into three levels, and the fraction with-
in each level is shown along with error bars indicating the standard error across two RNA-seq biological replicates.
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phasing (2716 “NP” promoters) and a second gaining phasing that
flanked anNDR (500 “NDR” promoters) (Fig. 3A). TheNP class had
strong enrichment of the poised H3K27me3 mark, in contrast to
the enrichment of the active H3K27ac in the NDR class (Fig. 3B),
which was consistent across replicates (Supplemental Fig. 4A).
This suggested a novel concept that highly organized nucleosomes
are compatible with promoters in the Polycomb/poised state.
Forty-five percent of the NDR genes became highly expressed in
DKO1 cells, compared to 21% of NP genes (Fig. 3C). This result
is consistent with previous observations that gene reactivation fol-
lowing DNA demethylation requires the formation of accessible or
NDR regions at the TSS (Lin et al. 2007; Yang et al. 2012). The ac-
quisition of H3K27me3 and phasing without nucleosome deple-
tion can be seen at the NP gene CYP4X1 gene promoter (Fig.
3D), in contrast to an NDR gene ZNF214 (Fig. 3E).
The gain of the Polycomb/poised signature at NP promoters
prompted us to investigate the status of these regions in normal
colon profiles from the Roadmap Epigenomics Consortium (Bern-
stein et al. 2010), since the presence of the Polycombmark in nor-
mal precursor cells is a strong predictor of methylation gain in
cancer (Ohm et al. 2007; Schlesinger et al. 2007; Widschwendter
et al. 2007) and is postulated to be part of a global “epigenetic
switch” from Polycomb repression to DNA methylation (Gal-Yam
et al. 2008; Jin et al. 2009). Indeed, the histone marks and ex-
pression levels of NP genes in DKO1 cells strongly resembled those
of normal colonic mucosa (Supplemental Fig. 5, left), suggesting
that the Polycomb to DNA methylation epigenetic switch in
cancer may be reversed by the removal of DNA methylation
(McGarvey et al. 2008). Remarkably, the active histone and expres-
sion patterns of NDR genes in DKO1 were also recapitulated in the
patterns of normal colonic mucosa (Supplemental Fig. 5, right).
The NDR promoters, unlike the NP promoters, were enriched for
binding motifs for specific transcription factors such as SP1 and
NRF1 (Supplemental Fig. 6), typical “housekeeping” transcription
factors that normally protect CGI promoters from methylation in
both normal and cancer cells (Gebhard et al. 2010; Berman et al.
2012).Howa small number of normally active promoters like these
can gain methylation in cancer (along with a larger set of poised
promoters which may be explained by the epigenetic switch) is
an open question, but our results here suggest that many could
be reversed by the removal of DNA methylation. Understanding
this processmay lead to insights into other similarly silenced genes
Figure 3. CGI promoters losingmethylation acquire either an active or poised chromatin state, eachwith a distinct nucleosomal profile and histonemod-
ifications that resemble their respective patterns in normal colon cells. (A) NOMe-seq reads were aligned to 3216 MU CGI TSS from Figure 2 and hierar-
chically clustered based on the accessibility level in DKO1 cells. Two top-level clusters were detected in the unsupervised clustering: NP gained nucleosome
positioning alone, while NDR promoters also gained nucleosome depletion. (B) Enrichment of each histonemark for the two clusters, displayed as in Figure
2. (C) Transcript level for each promoter class as displayed in Figure 2. (D) IGV browser view of NP gene CYP4X1 and (E) NDR gene ZNF214 (labeled as ∗D
and ∗E in A). IGV views show DNA methylation (CG) and accessibility (GC) NOMe-seq methylation levels and ChIP-seq histone marks, with HCT116 and
DKO1 plotted side by side. Methyltransferase accessible regions (MARs) and mononucleosomes were identified by our hidden Markov model (HMM), as
described in Methods.
DNA methylation has context-dependent role
Genome Research 471
www.genome.org
 Cold Spring Harbor Laboratory Press on May 21, 2015 - Published by genome.cshlp.orgDownloaded from 
like MLH1 in colorectal cancer and BRCA1 in breast and ovarian
cancer.
The loss of DNA methylation has little effect on the chromatin
structure of non-CGI promoters
Non-CGI promoters have regulatory characteristics distinct from
CGI promoters. As a group, they are more likely to be expressed
in a tissue-specific pattern, be associated with TATA boxes, and ini-
tiate transcription from a particular base pair rather than many
possible initiation sites within a “broad” region (Rach et al.
2011); they are also almost never repressed by Polycomb-associat-
edH3K27me3 (Mohn et al. 2008). By analyzing non-CGI using the
same methods as CGI promoters (Fig. 4), we found that the two
promoter types differed dramatically in their response to DNA
methylation loss. Unlike CGI promoters,most non-CGI promoters
are methylated, so the overwhelming majority (85%) fell into the
MU state. Only a small subset of non-CGI promoters had NDRs,
and these were limited to the UU class (Fig. 4A; Supplemental
Fig. 7). Unlike CGI promoters, we detectedweakly organized arrays
of nucleosomes at most MU promoters in HCT116 cells (Fig. 4A).
Well-positioned nucleosomes have often been described as a
feature of unmethylated and permissive promoters, but our find-
ing suggests that nucleosome organization can occur at non-CGI
promoters and is independent of methylation status. Autocorrela-
tion analysis showed that the extent of phasing changed little
between HCT116 and DKO1 cells (Fig. 4B). The loss of DNAmeth-
ylation in DKO1 cells also did not appear to influence the histone
modification patterns of non-CGI MU promoters, which were
devoid of both permissive and repressive histone marks (Fig. 4C;
Supplemental Fig. 8A,B) and were largely inactive (Fig. 4D).
These observations suggested that the loss of DNA methylation
alone was insufficient to remodel and reactivate a major class of
non-CGI promoters as it does for CGI promoters, and DNA meth-
ylation itself may not play an important role in modulating the
chromatin landscape of non-CGI promoters in cancer.
Long H3K9me3-marked heterochromatin domains
have lower chromatin accessibility and partially
methylated DNA
Having established the effects of genome-wide loss of DNA meth-
ylation on the focal chromatin structure of enhancers and promot-
ers, we next investigated the effects on higher-order chromatin
Figure 4. The loss of DNAmethylation has little effect on the chromatin structure of non-CGI promoters. (A) NOMe-seq methylation levels were aligned
to 7191 TSSs for annotated non-CGI promoters and displayed as in Figure 2. (B) Pearson autocorrelation of GC (accessibility) methylation levels was cal-
culated independently for each cell type and displayed as in Figure 2. (C) Within each promoter class, the Z-score enrichment level of each histone mark is
displayed as in Figure 2. (D) FPKM transcript values for all genes were divided into three levels and displayed as in Figure 2.
Lay et al.
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domains (Lister et al. 2011; Berman et al. 2012; Hon et al. 2012;
Bert et al. 2013). We ranked all nonoverlapping 1-Mb windows
in the genome based on the average GpC accessibility signal in
DKO1 cells (Fig. 5A), which was largely concordant between
HCT116 and DKO1 at this domain scale. We observed a distinct
set of windows at the right end of the Figure 5A plot that had rel-
atively low accessibility and DNA hypomethylation in both
HCT116 and DKO1. These regions of lower accessibility coincided
with partiallymethylated domains or PMDs (Fig. 5B), known to co-
incide with heterochromatic late-replicating regions in cancer
(Hansen et al. 2011; Lister et al. 2011; Berman et al. 2012; Hon
et al. 2012; Hovestadt et al. 2014). The low accessibility observed
within these domains (Fig. 5A,B)maybe due to a compact chroma-
tin structure (see Discussion) and coincided with the H3K9me3
mark observed in both cell types (Fig. 5A,B; Supplemental Fig. 9A).
Consistent with earlier reports (Hon et al. 2012; Gifford et al.
2013), the H3K9me3 domains were mutually exclusive with
H3K27me3 andH3K4me1. As illustrated by a representative region
on Chromosome 2 (Fig. 5B), many of the H3K9me3 domains
became shorter in DKO1 cells than in
the HCT116 cells, perhaps due to re-
establishment of H3K27me3 near the
domain boundaries occurring as part of
the epigenetic switch (see Discussion).
Surprisingly, the H3K9me3 domains
overlapped domains of H3K4me3 (Sup-
plemental Fig. 9A,B). LargeH3K4me3do-
mains have previously been associated
with the transcriptional consistency of
lineage-specific regions and activation
of the cancer genome (Bert et al. 2013;
Benayoun et al. 2014). The coexistence
of H3K4me and H3K9me3, however,
has not been described, and its signifi-
cance will require further investigation.
Discussion
The role of epigenetics in transcriptional
regulation is key to understanding the es-
tablishment of normal mammalian phe-
notypes and common diseases (Baylin
and Jones 2011). The remarkable growth
in the field of integrative epigenomics
has revealed that the functions of DNA
methylation may be more nuanced
than previously understood and act to-
gether with other chromatin features as
components of integrated epigenetic
states (Jones 2012; Bergman and Cedar
2013; Rivera and Ren 2013). Although
DNA methylation changes have been
associated with changes in transcrip-
tional state, our understanding of how
DNA methylation influences nucleoso-
mal changes has remained inconclusive
(Chodavarapu et al. 2010; Valouev et al.
2011; Kelly et al. 2012; Berman et al.
2013). Understanding the specific role
that DNA methylation plays in gene reg-
ulation thus requires a holistic examina-
tion of its interactions with other
epigenetic mechanisms, including histone modifications and nu-
cleosome positioning.
Here, we have investigated the epigenetic changes associated
with the abolishment ofDNAmethylation in cancer cells, combin-
ing NOMe-seq for single base-pair resolution maps of DNA meth-
ylation and nucleosome positioning with ChIP-seq for mapping
modified histones. At some genomic elements, such as CTCF insu-
lators and non-CpG island (non-CGI) promoters, we found little
change between the colon cancer cells (HCT116) and the methyl-
ation-deficient derivative cell line (DKO1). For enhancers, we
found that a small but significant subset was affected by loss of
DNAmethylation, with coordinated changes in nucleosome posi-
tioning and histone modifications. Loss of methylation only af-
fected a small subset of potential enhancers, with sequence
motifs suggesting that the specificity involves transcription factors
such as ARNT and FOS (AP-1 motif for FOS/JUN dimer). These
changes could be a direct (i.e., cis-acting) result of methylation
loss in a model where transcription factor complexes gain in-
creased access to DNA with the loss of methylation. However,
Figure 5. Long H3K9me3-marked heterochromatin domains have lower chromatin accessibility and
partially methylated DNA. (A) NOMe-seq methylation levels and ChIP-seq enrichment Z-scores (exclud-
ing those within CpG islands) were averaged within each 1-Mb window in the genome. Each dot in each
track shows the average value for the same 1-Mb window and which are ranked based on accessibility
level in DKO1 (starred). (B) IGV browser view for a 33-Mb genomic window on Chr 2q. Multiple biolog-
ical replicates are shown for H3K9me3 to illustrate the reproducibility in H3K9me3 domain shrinking.
DNA methylation has context-dependent role
Genome Research 473
www.genome.org
 Cold Spring Harbor Laboratory Press on May 21, 2015 - Published by genome.cshlp.orgDownloaded from 
such amodel is not required to explain these changes, as transcrip-
tion factor binding alone is sufficient to demethylate fullymethyl-
ated enhancer sequences in vivo, and demethylation occurs
genome-wide in vivo in short (several hundred bp) regions that
are defined by transcription factor binding sites (Stadler et al.
2011; Berman et al. 2012; Benveniste et al. 2014). The simpler
and perhaps more likely model is that the epigenomic changes
at DKO1 enhancers are indirect (trans-acting), with global DNA
methylation loss activating functional pathways that lead to
changes in transcription factor activity. Such indirect changes
are not unexpected, as DKO1 cells adapted to the loss of DNA
methylation over the course of many generations.
Our results at methylated CpG island promoters suggest a
more global and thereforemore likely cismechanism.CGI promot-
ers thatweremethylated inHCT116 cells (unlike non-CGI promot-
ers, discussed below) responded to loss of DNA methylation with
increased nucleosomal phasing and an acquisition of either active
or repressive histone marks. One subset of these promoters ac-
quired nucleosome-depleted regions along with active histone
marks (NDR subset), whereas a much larger subset gained nucleo-
some phasing but not nucleosome depletion, along with Poly-
comb-repressive marks characteristic of a poised chromatin state
(NP subset). Strikingly, the histonemodification patterns acquired
in these two subsets recapitulated their respective patterns in nor-
mal colonic mucosa. This suggests that DNA methylation has the
ability to suppressmultiple classes of CGI promoters during tumor-
igenesis, both active and poised, and that this suppression may be
reversed in a context-specificmannerwhenDNAmethylation is re-
moved. The NP class seems likely to represent a direct, cis-acting
consequence ofDNAmethylation loss. First, it is relativelynonspe-
cific, affecting85%ofCGIpromoters that becomedemethylated in
HCT116. Second, this class contains themajorityofCGI promoters
associated with the Polycomb (poised) state in normal colonicmu-
cosa, methylated en masse in cancers via a global “epigenetic
switch” (Gal-Yam et al. 2008; Baylin and Jones 2011). The fact
that these promoters regain their Polycomb-associated marks in
DKO1 cells suggests that Polycomb activity is directly repressed
by DNA methylation in HCT116 cells and can be reestablished
when DNA methylation is removed. The situation is somewhat
less clearat the15%ofmethylatedCGIpromoters that regainactive
status in DKO1 cells. Although they do reestablish a normal colon-
like chromatin state, they represent a tiny fraction of all CGI pro-
moters active in normal colon. How these promoters become spe-
cifically methylated in cancer is unknown, and our transcription
factor motif analysis here uncovers no additional candidates—
the transcription factor bindingmotifs enriched inNDRpromoters
in Supplemental Figure 6 belong to the same general transcription
factors found at all normally active CpG islands (Gebhard et al.
2010; Berman et al. 2012). This was in contrast to the motifs we
identified at remodeled enhancers,whichbelonged to cancer-relat-
ed transcription factors. Thismakes it difficult to concludewhether
NDR-acquiring CGI promoters are more likely to be the result of a
cis versus trans mechanism, but this question is central to under-
standing how CGI promoters for cancer driver genes like MLH1,
BRCA1, and VHL become epigenetically silenced in cancer.
Our results here underscore the fundamental differences be-
tween CpG island (CGI) and non-CGI promoters in mammals.
In HCT116 cells, methylated non-CGI promoters tended to have
weak nucleosome phasing without nucleosome depletion; in con-
trast, methylated CGI promoters had no detectable phasing. The
presence of weakly phased nucleosomes at methylated non-CGI
promoters had not been detected previously, even in our earlier
NOMe-seq study (Kelly et al. 2012). This was likely due to improve-
ments in our NOMe-seq protocol and several-fold greater sequenc-
ing coverage, but we cannot rule out cell type differences (our
earlier study focused on cultured fibroblast cells, whereas here we
focus on cancer cells). Weak nucleosome phasing at non-CGI pro-
moters is consistent with the intrinsic affinity of nucleosomes for
G/C rich sequences, which are abundant at promoters due to the
presence of G/C rich transcription factor binding sites (Tillo
et al. 2010). It must be noted that understanding the relative phas-
ing of nucleosomes relative to promoters is only as good as our
promoter annotations. Here we have used standard annotations
derived from a variety of RNA sequencing approaches; however,
the availability of large promoter databases determined using
5′ Cap Analysis of Gene Expression (CAGE)mapping, will improve
our ability to resolve phasing patterns relative to precise transcrip-
tional initiation sites (FANTOM Consortium and the RIKEN PMI
and CLST [DGT] et al. 2014).
Long (megabase-scale) domains of H3K9 methylation have
been linked to topological domains (Dixon et al. 2012) and associ-
ated with the nuclear lamina territory (Guelen et al. 2008) and late
replication timing (Hansen et al. 2010). In cancer, these domains
tend to become hypomethylated (Hansen et al. 2011; Berman
et al. 2012). Here, we show that NOMe-seq is able to detect these
regions as domains of relatively inaccessible DNA, presumably
due to the condensed structure of constitutive heterochromatin,
which acts as a diffusion barrier in vivo (Bancaud et al. 2009).
Domains of H3K9me3 and inaccessibility were highly overlapping
and often became shorter in DKO1 cells (Fig. 5B). Long domains
of H3K27me3 tend to occur just outside the edges of H3K9me3
domains (Guelen et al. 2008), perhaps mediating developmen-
tal gene silencing programs by dynamically controlling asso-
ciation and disassociation of genes with the nuclear lamina
(Peric-Hupkes et al. 2010). We propose that the “shrinking” of
H3K9me3-marked inaccessible chromatin domains that occurs
in DKO1 cells is due to the reestablishment of H3K27me3 domains
at the boundaries of H3K9me3, consistent with the reestablish-
ment of H3K27me3-marked poised chromatin at CGI promoters
genome-wide. This model predicts that topological domains and
DNA methylation may interact to define the epigenomic land-
scape of cancer.
Methods
Cell culture
HCT116, obtained from ATCC, and DKO1 cells were cultured un-
der recommended conditions at 37°C and 5% CO2 in McCoy’s 5A
media supplemented with 10% FBS and penicillin/streptomycin.
HCT116 was obtained from ATCC, and DKO1 was a generous
gift from Drs. Bert Vogelstein and Steve Baylin.
Genome-wide nucleosome footprinting assay
NOMe-seq was performed as previously described (Kelly et al.
2012). Briefly, exponentially growing cells were washed with
PBS, trypsinized, and incubated with ice-cold lysis buffer (10 mM
Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, and
0.5% NP-40) for 5 min on ice to isolate intact nuclei. Nuclei were
washed with ice-cold wash buffer (10 mM Tris, pH7.4, 10 mM
NaCl, 3 mM MgCl2, 0.1 mM EDTA), resuspended in ice-cold 1×
GpC buffer (New England BioLabs), and treated with 200 units
of M.CviPI enzyme supplemented with 1.5 μL S-adenosylmethio-
nine (SAM) for 7.5 min with a boost of 100 units enzyme and
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0.75 μL SAM for an additional 7.5min. Genomic DNAwas isolated
by standard phenol-chloroform extraction and ethanol precipita-
tion. WGBS libraries were generated using 2–5 μg of DNA as previ-
ously described and sequenced on HiSeq 2000 (Lister et al. 2009;
Berman et al. 2012). Sequencing reads were mapped to the hg19
genome, and methylation levels of CpG and GpC dinucleotides
were determined using the previously described pipeline (Kelly
et al. 2012; Liu et al. 2012). Sequencing metrics for NOMe-seq
data are listed in Supplemental Table 1.
Hidden Markov model-based approach of NDR detection
Two-state beta-binomial HMM was adapted from a previously de-
scribedmethod (Molaro et al. 2011) to segment regions intometh-
yltransferase accessible regions (MARs) and methyltransferase
protected regions (MPRs), based on GCH methylation in
HCT116 and DKO1 cells. Training of the model was performed in-
dependently for each biological replicate. GCH methylation and
read coverage were used as inputs to the Viterbi algorithm to deter-
mine the state of each individual GCH, and segments containing
at least three contiguous GCHs present in the same state were re-
quired to call the MARs and MPRs. A one-tailed binomial test
was used to calculate the significance level of eachMAR in compar-
ison to all MPRs present in the adjacent ±100-kb region, with only
MARs having FDR-corrected P-value <0.01 considered significant.
MARs having the length >100 bpwere considered as NDRs. For the
analysis of Figure 1 and Supplemental Figure 1, only NDRs that
overlapped in both biological replicates in each cell line were used.
Defining promoter methylation classes
We combined the two NOMe-seq replicates for each cell type and
filtered all annotated TSSs from the UCSC knownGenes track that
had at least three HCG sites and at least 10 reads from each cell
type within the region from −300 to +500 bp around the TSS.
We considered these TSS regions as unmethylated in a given cell
type if they had an averagemethylation level <5%. Formethylated
TSSs, we used 60% and 25% as the lower cutoff for HCT116 and
DKO1, respectively. These different cutoffs in the two cell types
were determined based on the global distribution of methylation
values in the promoter regions of each cell line. Based on this cri-
teria, we included 15,692 CGI promoters and 7191 non-CGI
promoters.
RNA-seq
HCT116 and DKO1 cells were washed with PBS and subsequently
lysed in TRIzol (Life Technologies). Total RNA from two inde-
pendent cultures was purified using Direct-zol RNA MiniPrep
(Zymo Research), and libraries were constructed using the poly
(A) selected method of the TruSeq RNA Sample Prep Kit
(Illumina) according to manufacturer’s instructions. Sequencing
reads were mapped to the hg19 reference genome using TopHat
v.1.2 (Trapnell et al. 2009), filtering out nonuniquely mapping
reads and PCR duplicates. FPKM value was calculated using
Cufflinks v.2.1.1 (Trapnell et al. 2010) with the following parame-
ters: -F 0.3 –u –b hg19.fa. Gene annotation was obtained as a GTF
file from the UCSCGenome Browser (knownGene track). RNA-seq
data of normal colonic mucosa was previously published and ob-
tained from The Cancer Genome Atlas (Berman et al. 2012; The
Cancer Genome Atlas Network 2012).
ChIP-seq
ChIP assay was performed in duplicate using 50 μg of chromatin as
previously described and according to ENCODE’s guideline (Kelly
et al. 2010; Landt et al. 2012). The following antibodies were used:
H2A.Z (Abcam, ab4174); H3K4me3 (Active Motif, 39160);
H3K4me1 (Active Motif, 39298); H3K27ac (Active Motif, 39297);
and H3K27me3 (Active Motif, 39155). Two biological replicates
of H3K9me3 and H3K36me3 as well as one biological replicate
of H3K27ac and Input HCT116 ChIP-seq data were produced
by the Farnham Laboratory, each as part of the ENCODE Project
Consortium (The ENCODE Project Consortium 2012) and is avail-
able at (http://genome.ucsc.edu). ChIP-seq data of normal colonic
mucosa was generated by the Bernstein Laboratory, as part of the
Roadmap Epigenomics Mapping Consortium (Bernstein et al.
2010); all data used in this study is past the 9-mo moratorium. A
complete list of sequencing metrics and GEO identifiers is includ-
ed in Supplemental Table 1 for all ChIP-seq data used in this study.
Briefly, genome-wide libraries were generated from 20 ng of
purified ChIP and input DNA, barcoded, and sequenced for 50 sin-
gle-end reads on HiSeq 2000 using a previously described protocol
(Barski et al. 2007; Kelly et al. 2012). Sequencing reads were
mapped to hg19 using BWA (Li and Durbin 2009), removing non-
uniquely mapping reads and PCR duplicates. All ChIP-seq reads
were extended to the sequencing library’s mean fragment size,
which was estimated using the default setting of HOMER v.4.3’s
makeTaqDirectory command (Heinz et al. 2010). Each data set
was normalized into a single value for each genomic position using
the Wiggler tool with default settings and “globalmap_k20tok54”
as the mappability parameter (The ENCODE Project Consortium
2012). Mean Wiggler values were calculated in 10-bp bins (Ger-
stein et al. 2012). To normalize variations between biological rep-
licates, we modified a previously described method to perform
Z-score transformation by subtracting the mean Wiggler value
across the genome and dividing by the standard deviation of the
genome-wide Wiggler subtraction value (Xie et al. 2013).
ChromHMM
Segmentation and determination of chromatin states were calcu-
lated as previously described (Ernst et al. 2011). Details are further
described in the Supplemental Methods. Emission and transition
parameters are shown in Supplemental Figure 10.
Source code access
All analyses were performed using the in-house Bis-tools package.
All source codes are available at https://github.com/dnaase/
Bis-tools and included in the Supplemental Material. Specific
scripts are detailed in the Supplemental Methods.
Data access
Data generated in this study have been submitted to the
NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.
nih.gov/geo/) under accession numbers GSE58695 and
GSE64929 (NOMe-seq), GSE58638 (ChIP-seq), and GSE52429
and GSE60106 (RNA-seq).
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